Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

No Comments

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Oct. 25, 1996

No Comments

Enzon selects Medac as marketing partner for Oncaspar

Oct. 25, 1996

No Comments

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

No Comments

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

No Comments

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

No Comments

Eisai claims RXR agonists

Oct. 18, 1996

No Comments

New antitumor agents from Sagami

Oct. 18, 1996

No Comments

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

No Comments

Banyu reports natural antitumor agent

Oct. 18, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

SRI and Taiho to develop new approach to breast cancer

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Enzon selects Medac as marketing partner for Oncaspar

Isis antisense compound and analogues covered by U.S. patent

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Natural antitumor indanone reported by Sagami

Eisai claims RXR agonists

New antitumor agents from Sagami

VCAM-1 inhibitors from Sagami

Banyu reports natural antitumor agent

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

Cancer RSS

Cancer
RSS